Prof. Jie Lin 林杰
Chief Physician, Professor
Department of General Surgery, Liaoning Cancer Hospital & Institute, Shenyang
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Complex hepatobiliary and pancreatic surgeries, including total pancreatectomy and liver resections. Treatment of gastrointestinal tumors, portal hypertension, breast cancer, thyroid cancer, and vascular diseases. Performs minimally invasive laparoscopic procedures.
Dr. Lin is Chief Physician and Professor in General Surgery at Liaoning Cancer Hospital & Institute. Holding MD and postdoctoral degrees, Dr. Lin graduated from China Medical University in 1992. Dr. Lin supervises master's students and has led provincial research projects, publishing numerous papers and co-editing a book on surgical treatment of liver diseases and portal hypertension.
Professional roles
- Standing Committee Member, Abdominal Tumor Professional Committee, China Medicine Education Association
- Standing Committee Member, Portal Hypertension Group, Peripheral Vascular Disease Professional Committee, Chinese Society of Microcirculation
- Vice Chair, Vascular Surgery Professional Committee, Liaoning Medical Association
- Vice Chair, Liaoning Branch, Neuroendocrine Tumor Professional Committee, China International Exchange and Promotion Association for Medical and Healthcare
Name order: in Chinese the family name comes first (Lin Jie). Papers usually list the name as Jie Lin or Lin J.
Selected publications
29 papers on PubMed matched by name and affiliation; 20 as first or senior author since 2016. Most recent first- or senior-author papers:
- Mol Cell Biochem, 2026 (senior author): SKA1 plays a tumor-promoting role in colorectal cancer: coupling TAF1‑dependent transcription with RPL8 interaction. PubMed 42909751
- Breast Cancer (Dove Med Press), 2023 (senior author): CD24 May Serve as an Immunotherapy Target in Triple-Negative Breast Cancer by Regulating the Expression of PD-L1. PubMed 38164371
- World J Oncol, 2023 (senior author): Construction and Validation of a Novel Nomogram for Predicting the Risk of Metastasis in a Luminal B Type Invasive Ductal Carcinoma Population. PubMed 38022397
- Front Bioeng Biotechnol, 2023 (senior author): Spotlights on extracellular vesicles in hepatocellular carcinoma diagnosis and treatment: an update review. PubMed 37456728
- Biosci Rep, 2021 (senior author): Hypoxia-induced PTTG3P contributes to colorectal cancer glycolysis and M2 phenotype of macrophage. PubMed 34132347
- Curr Probl Cancer, 2020 (senior author): Delaying adjuvant chemotherapy in advanced gastric cancer patients: Risk factors and its impact on survival outcome. PubMed 32418615
- J Clin Pathol, 2020 (senior author): Perineural invasion as a predictive factor for survival outcome in gastric cancer patients: a systematic review and meta-analysis. PubMed 31980559
- Expert Rev Gastroenterol Hepatol, 2020 (senior author): Different prognostic significance of signet ring cell histology for early and advanced gastric cancer patients: a systematic review and meta-analysis. PubMed 32421372
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital. This name is shared by other researchers, so we checked that the papers match this doctor's specialty; this check is automatic.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion